Viviane Sampaio Boaventura de Oliveira
Pesquisadora da Fundação Oswaldo Cruz- Centro de Pesquisas Goncalo Moniz, professora adjunta e coordenadora da disciplina de Imunopatologia da Faculdade de Medicina da Universidade Federal da Bahia. Colabora como preceptora da residência médica em Otorrinolaringologia na Santa Casa de Misericórdia da Bahia. Possui graduação em Medicina pela Universidade Federal da Bahia (1999) e especialização em Otorrinolaringologia na Santa Casa de Misericóridia da Bahia. Concluiu curso de mestrado (2005) e doutorado (2009) em Patologia pela Universidade Federal da Bahia/ Centro de Pesquisas Gonçalo Moniz - FIOCRUZ e em 2011 concluiu pós-doutorado na Fiocruz-Bahia.Tem experiência na área de Medicina, com ênfase em imunopatologia e otorrinolaringologia, atuando principalmente nos seguintes temas: imunopatogênese e diagnóstico de doenças transmitidas por vetores (Leishmania e arbovirus).
- Amanda Canário Andrade Azevedo - Mestrado 2016
- Blenda de Jesus Pereira - Doutorado 2024.1
- Jéssica de Jesus Silva - Doutorado 2023.2
- Jéssica de Jesus Silva - Mestrado 2021
- Márcia Rejane Freire de Oliveira - MESTRADO 2019
- Michelle Queiroz Aguiar Brasil - MESTRADO 2019
- Paula Milena Casais - Mestrado 2017
- Paula Milena Melo Casais - DOUTORADO 2019.1
- Thiago Cerqueira Silva - Doutorado 2022.1
- The re-emergence of Zika in Brazil in 2020: A case of Guillain Barré Syndrome during the low season for arboviral infections.
- A clinical scoring system to predict long-term arthralgia in Chikungunya disease: A cohort study.
- A double-bind and randomized trial to evaluate Miltefosine and topical GM-CSF in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil.
- Analyses of Early ZIKV Genomes Are Consistent with Viral Spread from Northeast Brazil to the Americas.
- Bridging Learning in Medicine and Citizenship During the COVID-19 Pandemic: A Telehealth-Based Case Study.
- Chikungunya virus antepartum transmission and abnormal infant outcomes in a cohort of pregnant women in Nigeria.
- CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study.
- Differential expression of polyamine biosynthetic pathways in skin lesions and in plasma reveals distinct profiles in diffuse cutaneous leishmaniasis.
- Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil.
- Effectiveness of BNT162b2 booster after CoronaVac primary regimen in pregnant people during omicron period in Brazil.
- Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study.
- Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case-control study
- Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case-control study.
- Evaluation of ELISA-Based Multiplex Peptides for the Detection of Human Serum Antibodies Induced by Zika Virus Infection across Various Countries.
- High seroprevalence of Leishmania infantum is linked to immune activation in people with HIV: a two-stage cross-sectional study in Bahia, Brazil.
- Inflammasome activation by CD8+ T cells from Patients with Cutaneous Leishmaniasis caused by Leishmania braziliensis in the immunopathogenesis of the disease.
- Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study.
- Integrated Analysis Reveals That miR-193b, miR-671, and TREM-1 Correlate With a Good Response to Treatment of Human Localized Cutaneous Leishmaniasis Caused by Leishmania braziliensis
- Integrated Analysis Reveals That miR-193b, miR-671, and TREM-1 Correlate With a Good Response to Treatment of Human Localized Cutaneous Leishmaniasis Caused by Leishmania braziliensis.
- LTB 4 -driven inflammation and increased expression of ALOX5/ACE2 during severe COVID-19 in individuals with diabetes..
- Lutzomyia longipalpis Saliva Induces Heme Oxygenase-1 Expression at Bite Sites.
- Metabolic disorders and post-acute hospitalization in black/mixed-race patients with long COVID in Brazil: A cross-sectional analysis.
- Métodos para avaliação da efetividade de vacinas para COVID-19 com ênfase em abordagens quase-experimentais.
- Oral lesions are frequent in patients with Chikungunya infection.
- Prediabetes Induces More Severe Acute COVID-19 Associated With IL-6 Production Without Worsening Long-Term Symptoms.
- Presence of parasite DNA in clinically unaffected nasal mucosa during Cutaneous Leishmaniasis caused by Leishmania (V.) braziliensis.
- Presence of parasite DNA in clinically unaffected nasal mucosa during Cutaneous Leishmaniasis caused by Leishmania (V.) braziliensis.
- Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group.
- Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality: a cohort study from Brazil.
- Selective suppression of cellular immunity and increased cytotoxicity in skin lesions of disseminated leishmaniasis uncovered by transcriptome-wide analysis.
- Syndromic Surveillance Using Structured Telehealth Data: Case Study of the First Wave of COVID-19 in Brazil
- Syndromic Surveillance Using Structured Telehealth Data: Case Study of the First Wave of COVID-19 in Brazil.
- Systems Approach Reveals Nuclear Factor Erythroid 2-Related Factor 2/Protein Kinase R Crosstalk in Human Cutaneous Leishmaniasis.
- The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era.
- The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era.
- The Long Pentraxin 3 (PTX3) Suppresses Immunity to Cutaneous Leishmaniasis by Regulating CD4+ T Helper Cell Response.
- Transcriptome Analysis Identifies the Crosstalk between Dendritic and Natural Killer Cells in Human Cutaneous Leishmaniasis.
- Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.
- Vaccination plus previous infection: protection during the omicron wave in Brazil.
- Vaccine coverage and effectiveness against laboratory-confirmed symptomatic and severe Covid-19 in indigenous people in Brazil: a cohort study.
- Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period.
- Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil.